Search research articles
Contact Us
Filters
Showing results (11-20 of 122) with videos related to
Page
of 13
Sort By:
Anti-Cancer Drugs
|
December 25, 2012
Cervical extravasation of bevacizumab
Johann Dréanic, Romain Coriat, Olivier Mir, et al.
Journal of the Endocrine Society
|
December 22, 2017
Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma
Léopoldine Bricaire, Chiara Villa, Mathilde Brière, et al.
Bulletin Du Cancer
|
November 26, 2018
[Efficacy and toxicity of immune checkpoint inhibitors in elderly patients - 5th edition of the congress of pharmacology of anticancer drugs]
Hortense Gaultier De Saint Basile, Caroline Poisson, Jennifer Arrondeau, et al.
American Journal of Clinical Oncology
|
October 10, 2018
How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools
Frédéric Pamoukdjian, Evelyne Liuu, Philippe Caillet, et al.
The American Journal of Clinical Nutrition
|
March 31, 2017
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy
Clara Vazeille, Anne Jouinot, Jean-Philippe Durand, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 23, 2013
An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients
Yi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, et al.
Bulletin Du Cancer
|
March 12, 2025
[Extra-pulmonary metastatic Ewing sarcoma: The French GroupOs diagnostic and therapeutic recommendations]
Sarah Winter, Thibaud Valentin, Anne Ducassou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 31, 2012
Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study
Olivier Mir, Jean-Philippe Durand, Pascaline Boudou-Rouquette, et al.
Journal of Oncology Practice
|
November 28, 2012
Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy
Romain Coriat, Pascaline Boudou-Rouquette, Jean-Philippe Durand, et al.
The Oncologist
|
July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis
Pascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 122) with videos related to
Sort By:
Page
of 13
Anti-Cancer Drugs
|
December 25, 2012
Cervical extravasation of bevacizumab
Johann Dréanic, Romain Coriat, Olivier Mir, et al.
Journal of the Endocrine Society
|
December 22, 2017
Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma
Léopoldine Bricaire, Chiara Villa, Mathilde Brière, et al.
Bulletin Du Cancer
|
November 26, 2018
[Efficacy and toxicity of immune checkpoint inhibitors in elderly patients - 5th edition of the congress of pharmacology of anticancer drugs]
Hortense Gaultier De Saint Basile, Caroline Poisson, Jennifer Arrondeau, et al.
American Journal of Clinical Oncology
|
October 10, 2018
How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools
Frédéric Pamoukdjian, Evelyne Liuu, Philippe Caillet, et al.
The American Journal of Clinical Nutrition
|
March 31, 2017
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy
Clara Vazeille, Anne Jouinot, Jean-Philippe Durand, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 23, 2013
An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients
Yi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, et al.
Bulletin Du Cancer
|
March 12, 2025
[Extra-pulmonary metastatic Ewing sarcoma: The French GroupOs diagnostic and therapeutic recommendations]
Sarah Winter, Thibaud Valentin, Anne Ducassou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 31, 2012
Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study
Olivier Mir, Jean-Philippe Durand, Pascaline Boudou-Rouquette, et al.
Journal of Oncology Practice
|
November 28, 2012
Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy
Romain Coriat, Pascaline Boudou-Rouquette, Jean-Philippe Durand, et al.
The Oncologist
|
July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis
Pascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Page
of 13